NCT05100121 To Live Better After Prostate Cancer Treatment:
| NCT ID | NCT05100121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Prostate Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-10-17 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-10-17 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is evident that patients receiving treatment for cancer have symptoms that often are undetected. Furthermore, many survivors from cancer have ongoing poor health and well-being and long-term rehabilitation and support should not be neglected to prevent recurrence and increase survival. There are good reasons to believe that routine collection of relevant patient-reported symptoms facilitates person-centered care where the patient is a participatory member of the team. This study aims to pilot-test a supportive intervention in primary care for six months during the first year after primary treatment for prostate cancer in primary care and compare it to standard care only. The intervention consists of symptom reporting and self-management in an app in combination with health dialogues with a study-specific nurse at a primary care centre.
Eligibility Criteria
Inclusion Criteria: * patients with prostate cancer at the end of curative treatment * able to read and understand Swedish * considered being physically, psychologically and cognitively able to participate in the study
Contact & Investigator
Ann Langius-Eklöf, Professor
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT05100121 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05100121 currently recruiting?
Yes, NCT05100121 is actively recruiting participants. Contact the research team at nazmije.kelmendi@ki.se for enrollment information.
Where is the NCT05100121 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT05100121 clinical trial?
NCT05100121 is sponsored by Karolinska Institutet. The principal investigator is Ann Langius-Eklöf, Professor at Karolinska Institutet. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.